Home/Filings/4/0001447028-20-000031
4//SEC Filing

Howard Elizabeth 4

Accession 0001447028-20-000031

CIK 0001447028other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 8:05 AM ET

Size

8.6 KB

Accession

0001447028-20-000031

Insider Transaction Report

Form 4
Period: 2020-02-17
Howard Elizabeth
Exec. VP & General Counsel
Transactions
  • Award

    Stock Options

    2020-02-17+79,50079,500 total
    Exercise: $3.35Exp: 2030-02-17Common Stock (79,500 underlying)
Footnotes (1)
  • [F1]The stock option will vest and become exercisable 1/48th each month over the four year period.

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1
  • filerCIK 0001669530

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:05 AM ET
Size
8.6 KB